Prognostic Value of Programmed Cell Death-Ligand 1 Expression in Tumor-Infiltrating Lymphocytes and Viral Load in Peripheral Blood Mononuclear Cells for Epstein–Barr Virus–Positive Nasopharyngeal Carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Value of Programmed Cell Death-Ligand 1 Expression in Tumor-Infiltrating Lymphocytes and Viral Load in Peripheral Blood Mononuclear Cells for Epstein–Barr Virus–Positive Nasopharyngeal Carcinoma
Authors
Keywords
-
Journal
CLINICAL CHEMISTRY
Volume 66, Issue 9, Pages 1219-1227
Publisher
Oxford University Press (OUP)
Online
2020-08-22
DOI
10.1093/clinchem/hvaa170
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade
- (2019) Maria Pia Pistillo et al. Cellular & Molecular Immunology
- The host protecting the tumor from the host — targeting PD‑L1 expressed by host cells
- (2018) David H. Munn JOURNAL OF CLINICAL INVESTIGATION
- Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort Study
- (2018) Qiu-Yan Chen et al. Cancer Research and Treatment
- Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond
- (2018) Kristina Buder-Bakhaya et al. Frontiers in Immunology
- The addition of pretreatment plasma Epstein-Barr virus DNA into the 8th edition of nasopharyngeal cancer TNM stage classification
- (2018) Victor Ho-Fun Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials
- (2018) Wenfeng Fang et al. LANCET ONCOLOGY
- Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality
- (2018) Sara R. Selitsky et al. mSystems
- Trial watch: The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
- (2018) Jun Tang et al. NATURE REVIEWS DRUG DISCOVERY
- EBV-positive diffuse large B-cell lymphoma features PD-L1 protein but not mRNA overexpression
- (2018) Tian Xue et al. PATHOLOGY
- Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer
- (2017) K.C. Allen Chan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epstein–Barr virus infection and nasopharyngeal carcinoma
- (2017) Sai Wah Tsao et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT)
- (2017) Ya-bin Jin et al. PLoS One
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients
- (2017) Xiaofang Xing et al. OncoImmunology
- Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma
- (2016) Nghia Nguyen et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Nasopharyngeal carcinoma
- (2016) Melvin L K Chua et al. LANCET
- Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1+ immune cells in Epstein–Barr virus-associated gastric cancer: the prognostic implications
- (2016) Ruri Saito et al. MODERN PATHOLOGY
- Comparison of (18)F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis
- (2016) Junbao Wei et al. ORAL ONCOLOGY
- Prognostic utility of 18F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site
- (2016) Peter Lin et al. RADIOTHERAPY AND ONCOLOGY
- Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
- (2015) Anne W.M. Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma
- (2015) Jianwei Zhang et al. MEDICAL ONCOLOGY
- Nasopharyngeal Carcinoma
- (2015) Sophia C. Kamran et al. Surgical Oncology Clinics of North America
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Epstein-Barr Virus DNA Load in Nasopharyngeal Brushings and Whole Blood in Nasopharyngeal Carcinoma Patients before and after Treatment
- (2013) M. Adham et al. CLINICAL CANCER RESEARCH
- Determining EBV load: current best practice and future requirements
- (2013) Stephanie Ruf et al. Expert Review of Clinical Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started